Remicade (infliximab) - J&J
Rituxan (rituximab) - Roche
Humira (adalimumab) - AbbVie
tofacitinib - Generic mfg.
Kineret (anakinra) - SOBI
Stelara (ustekinumab) - J&J
Simponi (golimumab) - J&J
Enbrel (etanercept) - Pfizer, Amgen
Stalaris (efzofitimod) - aTyr Pharma, Kyorin
Kevzara (sarilumab) - Asahi Kasei, Regeneron, Sanofi
http://www.ncbi.nlm.nih.gov/pubmed/40393718
 
Aitana Miracle; Amit S Patel; James Galloway; Katherine J Myall; Kathryn Biddle; Katie Bechman; Kelly He; Mark D Russell; Mark Gibson; Peter Brex; Sam Norton; Sarah Walsh; Surinder S Birring
 
May 21, 2025
 
Prev Next